Our verdict
Trellis publishes compounded GLP-1 prices at several plan lengths, while the reviewed public materials leave its longevity charges unpublished. The semaglutide price comparison helps assess the GLP-1 offer using the full charge and prescribed supply for the selected term. Confirm the assigned pharmacy and renewal terms, and request a separate written quote for any NAD+ care.
Main trade-offs
- No price is published for NAD+, its own flagship protocol — nor for tesamorelin or glutathione
- The only figure on the NAD+ page is a competitor's infusion cost, which invites a comparison the reader cannot complete
Disclosure: Aminoscope is reader-supported. We may earn a commission from partner links, at no extra cost to you. This never changes our assessment. How we make money.
Compounded medicines are not FDA-approved. A licensed clinician must assess whether treatment is appropriate; availability does not establish safety or benefit.
Good fit
Buyers who want a flat GLP-1 price at every dose from a named pharmacy, or who specifically want a longevity protocol gated behind real lab work and are willing to ask for the cost before starting.
Consider other options if
Anyone comparison-shopping NAD+ on price, or anyone who wants published outcome claims to come with a citation attached.
Cost and care at a glance
- Category
- Longevity telehealth
- Published cost
- No price published for its own flagship NAD+ protocol — the only figure on the page is a rival clinic’s infusion cost
- Insurance
- Cash-pay, no insurance
- Visit
- Quiz intake / Async intake
- Availability
- All 50 states
- LegitScript
- Claimed by provider
Our review in detail
Full assessment
Trellis is two things at once. Its GLP-1 line is honestly structured: one flat price at every dose, $150/mo semaglutide and $199/mo tirzepatide, from a named medical group and a named compounding pharmacy. Its longevity line — the thing the company is actually built around — publishes no price anywhere we could reach, and leans on outcome statistics that carry no source. A clinic that quotes what a competitor's infusion costs on its own NAD+ page, while omitting its own figure, is asking you to start an intake before you can compare. Worth considering for the GLP-1 line; ask for the NAD+ price in writing before you commit to anything else.
What it is
A virtual longevity clinic organized around at-home lab testing and a 90-day biomarker re-test rather than a product catalog. Its self-described flagship is subcutaneous NAD+; it also offers glutathione, tesamorelin, a Lipo-MIC/B12 shot and a compounded GLP-1 line.
How care works
You begin with a free online Vitality Assessment; a licensed clinician reviews the intake and labs and prescribes only where clinically appropriate, with a re-test at 90 days meant to demonstrate whether anything moved. The designated medical group is Arora Health & Aesthetics, LLC, with Dr. Sean Arora named as medical director. Prescriptions are fulfilled by VialsRX, a state-licensed compounding pharmacy in Houston, Texas. Intake runs on an externally hosted funnel. Trellis states availability in all 50 states and displays a LegitScript certification. It is also one of the very few providers in this category to publish an llms.txt, which sets out its medical group, pharmacy and compounding disclosures in plain machine-readable text — a transparency gesture we would like to see more of.
Costs, billing and cancellation
Split, and the split is the problem. The GLP-1 line is priced clearly and well: the same rate at every dosage, with semaglutide at $150/mo month-to-month, $140 on a three-month plan and $133 on six, and tirzepatide at $199/$189/$179 on the same terms. Flat-at-every-dose pricing is genuinely consumer-friendly and rarer than it should be. Nothing else on the site carries a price. The NAD+ page — for the protocol Trellis calls its flagship — quotes a single dollar figure and it belongs to somebody else: "$200–500 per clinic infusion," the cost of the alternative it is arguing against. Its own rate appears nowhere on the product page, in the intake funnel, or anywhere else we could reach without starting a visit. The tesamorelin and glutathione pages publish no figure at all.
Medication and evidence
All compounded, and Trellis states plainly that compounded medications are not FDA-approved as finished products. The GLP-1 line is compounded semaglutide and tirzepatide. The longevity line is subcutaneous NAD+, glutathione, tesamorelin and a lipotropic Lipo-MIC/B12 injection. On the evidence: injected NAD+ has no controlled human outcome trials, and the randomized support belongs to the oral NR and NMN precursors, where what was demonstrated is a raised blood NAD+ level rather than a clinical outcome — a distinction Trellis's own blog actually handles carefully, which makes the unsourced homepage statistics more frustrating rather than less. Tesamorelin is the one growth-hormone-axis peptide here with an FDA-approved reference product (Egrifta, for HIV-associated lipodystrophy), so its evidence base is better than sermorelin's, though not for general longevity use. Injected glutathione has essentially no controlled human outcome data.
Pros and watch-outs
What we like
- Names both sides of the care chain — Arora Health & Aesthetics under Dr. Sean Arora, and VialsRX as the dispensing pharmacy
- GLP-1 pricing is flat at every dose, so titrating up does not raise your bill
- Genuinely cheap GLP-1 rates: $150/mo semaglutide and $199/mo tirzepatide month-to-month
- Lab-gated model with an at-home baseline and a 90-day biomarker re-test
- Publishes an llms.txt disclosing its medical group, pharmacy and compounding status
- Its blog handles the NAD+ versus NR/NMN evidence question more carefully than most sellers
Watch-outs
- No price is published for NAD+, its own flagship protocol — nor for tesamorelin or glutathione
- The only figure on the NAD+ page is a competitor's infusion cost, which invites a comparison the reader cannot complete
- "92% of patients see significant biomarker improvements within 90 days" appears with no study, sample size or methodology
- "$4,000 average patient savings per year" and "3.4 weeks average patient time saved" are unsourced in the same way
- The four named patient testimonials on the homepage are the same four quotes repeated three times in the carousel
- Shares its medical group with The Edit and its pharmacy with AurenRx, both of which we also review
Best for
Buyers who want a flat GLP-1 price at every dose from a named pharmacy, or who specifically want a longevity protocol gated behind real lab work and are willing to ask for the cost before starting.
Who should look elsewhere
Anyone comparison-shopping NAD+ on price, or anyone who wants published outcome claims to come with a citation attached.
Research relevant to Trellis Vitality
Explore the evidence and its limits. Findings apply to the formulation, route and population studied; they do not establish the quality or effectiveness of a provider’s products.
- NAD+ precursors (NR and NMN): what the human trials actually show
They raise NAD+ and look safe short-term, but human evidence is surrogate-marker level, and no trial shows they extend healthspan.
- Tesamorelin (Egrifta): what it's actually FDA-approved for, and the evidence
A real, approved GHRH analog — for HIV-associated lipodystrophy specifically. What the pivotal trials showed, and why the longevity use is an extrapolation.
- Glutathione: the master antioxidant, and where the evidence actually is
Oral glutathione really does raise your body stores (a 6-month RCT proved it) — but the longevity and detox claims are unproven, skin-lightening is modest, and IV glutathione is the most marketed, least evidenced route. The precursors may be the smarter bet.
- What the semaglutide weight-loss trials actually showed
STEP 1, STEP 4 and SELECT, plus oral and higher-dose semaglutide trials: weight loss, withdrawal, cardiovascular benefit and the limits of comparison.
- Tirzepatide vs semaglutide for weight loss: what the trials actually support
SURMOUNT-5 found 20.2% versus 13.7% average weight loss. What that direct comparison supports, which doses it tested, and why newer formulations need separate evidence.
How Trellis Vitality compares
A few alternatives worth a look, depending on what you’re optimizing for.
Our Shed review and Live Vital review describe what each service publishes about pricing, billing and cancellation.
- Shed
NAD⁺ from a provider that also handles GLP-1 and longevity protocols
See Shed → - Live Vital
NAD⁺ bundled with peptides and a body-recomposition protocol
See Live Vital →
the edit.Buyers who want the management company and practice identified and will confirm the dispensing pharmacy
See the edit. →
More NAD⁺ telehealth reviews: Elevated HealthKIN HealthLavender Sky HealthLaylaLifeRx.mdLivea
Access & cost
How we assessed this. This review is based on Trellis Vitality’s own website and published terms, read for pricing transparency, clinical oversight, medication clarity and access against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- How much does Trellis charge for NAD+?
- It does not say. Neither the NAD+ product page, the intake funnel nor any other page on the site publishes a figure for the NAD+ protocol. The only price on that page is what a clinic infusion costs elsewhere ($200–500). You will need to ask Trellis directly or begin the free assessment.
- What does Trellis's GLP-1 line cost?
- Semaglutide is $150/mo month-to-month, $140/mo on a three-month plan and $133/mo on six. Tirzepatide is $199, $189 and $179 on the same terms. Notably, the price is the same at every dosage, so it does not rise as your clinician titrates you up.
- Is the "92% of patients" figure backed by anything?
- Not that Trellis publishes. The claim appears on the homepage as "92% of patients see significant biomarker improvements within 90 days," annotated only as "confirmed on your 90-day re-test, not self-reported." No study, sample size, time period or methodology is given, and we found no supporting document anywhere on the site.
- Who fills a Trellis prescription?
- VialsRX, a state-licensed compounding pharmacy in Houston, Texas. The prescribing group is Arora Health & Aesthetics, LLC, with Dr. Sean Arora as medical director. Both are named in Trellis's own llms.txt.
- Does injected NAD+ have evidence behind it?
- Not for clinical outcomes. No controlled human outcome trial supports injected or intranasal NAD+. The randomized evidence in this area belongs to the oral precursors NR and NMN, and even there the demonstrated result is a raised blood NAD+ level rather than a proven health benefit.
- Is Trellis Vitality legit?
- Trellis Vitality is a longevity telehealth service you reach through an online questionnaire and an online intake a clinician reviews. Its stated availability: All 50 states. What it publishes up front: No price published for its own flagship NAD+ protocol — the only figure on the page is a rival clinic’s infusion cost. It is cash-pay and states it does not bill insurance. It shows a LegitScript seal. Ask the company for its certificate number before you rely on it. Before you pay, ask in writing about your selected charge, billing interval, supply and required fees and which medications it dispenses.
